Additionally, TREM2 or TYROBP loss of function mutations result in Nasu-Hakola disease (NHD), also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), characterized by microglial activation and dementia. Here, TREM2 is linked to Nasu-Hakola disease.